Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 24

Trial Status

Completed4

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT02019459Phase 2Completed
Very Low Nicotine Cigarettes in Smokers With Schizophrenia
Tobacco Dependence
PrincipalinvestigatorStart date: 2014-11-17
NCT01213524Phase 2Completed
Nicotine and Sensorimotor Replacement for Smoking in Smokers With Schizophrenia
SchizophreniaTobacco Use Disorder
Principalinvestigator
NCT01214005Phase 2Completed
Smoking Abstinence and Lapse Effects in Smokers With Schizophrenia and Controls
SchizophreniaTobacco Use Disorder
Principalinvestigator
NCT01635075Phase 2Completed
Acute Effects of Exercise in Smokers With Schizophrenia
Cigarette CravingSmoking BehaviorTobacco Dependence
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Nancy A Rigotti, MD

Massachusetts General Hospital

Related
9 trials

Shared therapeutic areas:

Tobacco Use DisorderTobacco Dependence

Worked with same sponsors:

University of Pittsburgh
Similarity Score12%

Dorothy Hatsukami, PhD

University of Minnesota

Related
13 trials

Shared therapeutic areas:

Tobacco Use DisorderTobacco Dependence

Worked with same sponsors:

Brown UniversityNational Institute on Drug Abuse (NIDA)
Similarity Score12%

Elliot Stein, Ph.D.

National Institute on Drug Abuse (NIDA)

Related
20 trials

Shared therapeutic areas:

SchizophreniaTobacco Use Disorder

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score12%

A. Eden Evins, MD, MPH

Massachusetts General Hospital

Related
9 trials

Shared therapeutic areas:

SchizophreniaTobacco Dependence

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score12%

John R Knight, MD

Boston Children's Hospital

Related
9 trials

Shared therapeutic areas:

Tobacco DependenceTobacco Use Disorder
Similarity Score12%

Sanjeev Pathak, MD

Alkermes, Inc.

Related
13 trials

Shared therapeutic areas:

Schizophrenia
Similarity Score6%

Jean-Olivier ARNAUD, Director

Assistance Publique Hôpitaux de Marseille

Related
17 trials

Shared therapeutic areas:

Schizophrenia
Similarity Score6%

Urielle Desalbres

Assistance Publique Hôpitaux de Marseille

Related
71 trials

Shared therapeutic areas:

Schizophrenia
Similarity Score6%

Nobuhito Sanada

Otsuka Pharmaceutical Co., Ltd.

Related
11 trials

Shared therapeutic areas:

Schizophrenia
Similarity Score6%

Walter Ling, M.D.

Friends Research Institute, Inc.

Related
28 trials

Shared therapeutic areas:

Tobacco Use Disorder

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT02019459Phase 2PrincipalInvestigator

Very Low Nicotine Cigarettes in Smokers With Schizophrenia

Tobacco Dependence
Completed
NCT01213524Phase 2PrincipalInvestigator

Nicotine and Sensorimotor Replacement for Smoking in Smokers With Schizophrenia

SchizophreniaTobacco Use Disorder
Completed
NCT01214005Phase 2PrincipalInvestigator

Smoking Abstinence and Lapse Effects in Smokers With Schizophrenia and Controls

SchizophreniaTobacco Use Disorder
Completed
NCT01635075Phase 2PrincipalInvestigator

Acute Effects of Exercise in Smokers With Schizophrenia

Cigarette CravingSmoking BehaviorTobacco Dependence
Completed

All 4 trials loaded